These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10545619)

  • 1. Diabetes mellitus: biological determinants of atherosclerosis and restenosis.
    Marso SP; Mak KH; Topol EJ
    Semin Interv Cardiol; 1999 Sep; 4(3):129-43. PubMed ID: 10545619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
    Wiersma JJ; Trip MD; Piek JJ
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cardiologist view of vascular disease in diabetes.
    Lockhart CJ; Hamilton PK; McVeigh KA; McVeigh GE
    Diabetes Obes Metab; 2008 Apr; 10(4):279-92. PubMed ID: 17941877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
    Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer MJ; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc JJ; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyörälä K; Raz I; Schernthaner G; Volpe M; Wood D; ;
    Eur Heart J; 2007 Jan; 28(1):88-136. PubMed ID: 17220161
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
    Schiel R; Heinrich S; Steiner T; Ott U; Stein G
    Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perioperative treatment of patients with type 1 and type 2 diabetes.
    Ghirlanda G; Mancini L
    Clin Podiatr Med Surg; 2007 Jul; 24(3):365-82; vii. PubMed ID: 17613381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart disease in diabetic patients.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):372-8. PubMed ID: 16298258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of silent coronary artery disease in type 2 diabetes.
    Zellweger MJ
    Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus.
    Galla JM; Nicholls SJ
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):85-93. PubMed ID: 19105770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of present management.
    Baskett RJ; Buth KJ; Collicott C; Ross DB; Hirsch GM
    Can J Cardiol; 2002 Apr; 18(4):397-402. PubMed ID: 11992133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.